Suppr超能文献

儿童呼吸衰竭管理的进展。

Advances in Management of Respiratory Failure in Children.

机构信息

Department of Pediatrics, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.

出版信息

Indian J Pediatr. 2023 May;90(5):470-480. doi: 10.1007/s12098-023-04559-z. Epub 2023 Apr 3.

Abstract

Providing the right respiratory support is an essential skill, vital for anyone treating sick children. Recent advances in respiratory support include developments in both non-invasive and invasive ventilatory strategies. In non-invasive ventilation, newer modalities are being developed, in an attempt to decrease the need for invasive ventilation. This include newer techniques like Heated humidified high-flow nasal cannula (HHHFNC) and improvements in existing modes. The success of Continuous positive airway pressure (CPAP) and other non-invasive modes depend to a large extent on choosing and maintaining a suitable interface. When it comes to invasive ventilation, recent advances are focussing on increasing automation, improving patient comfort and minimising lung injury. Concepts like mechanical power are attempts at understanding the mechanisms of unintended injuries resulting from respiratory support and newer monitoring methods like transpulmonary pressure, thoracic impedance tomography are attempts at measuring potential markers of lung injury. Using the vast arrays of available ventilatory options judiciously, considering their advantages and drawbacks in every individual case will be the prime responsibility of clinicians in the future. Simultaneously, efforts have been made to identify potential drugs that can favourably modify the pathophysiology of acute respiratory distress syndrome (ARDS). Unfortunately, though eagerly awaited, most pharmaceutical agents tried in pediatric ARDS have not shown definite benefit. Pulmonary local drug and gene therapy using liquid ventilation strategies may revolutionize our future understanding and management of lung diseases.

摘要

提供正确的呼吸支持是一项基本技能,对于治疗患病儿童的任何人来说都是至关重要的。呼吸支持方面的最新进展包括非侵入性和侵入性通气策略的发展。在非侵入性通气中,正在开发新的模式,以试图减少对侵入性通气的需求。这包括新的技术,如加热加湿高流量鼻导管(HHHFNC)和现有模式的改进。持续气道正压通气(CPAP)和其他非侵入性模式的成功在很大程度上取决于选择和维持合适的接口。在侵入性通气方面,最近的进展集中在提高自动化程度、提高患者舒适度和尽量减少肺损伤上。机械功率等概念试图理解呼吸支持引起的意外损伤的机制,而 Transpulmonary 压力等新的监测方法和胸部阻抗断层摄影术试图测量肺损伤的潜在标志物。未来的临床医生将需要明智地使用大量可用的通气选项,考虑其在每个个体病例中的优缺点。同时,也在努力寻找可能有利于急性呼吸窘迫综合征(ARDS)病理生理学改变的潜在药物。不幸的是,尽管人们热切期待,但在儿科 ARDS 中尝试的大多数药物都没有显示出明确的益处。使用液体通气策略的肺部局部药物和基因治疗可能会彻底改变我们对肺部疾病的未来理解和管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验